Multiple sclerosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: For people with multiple sclerosis (MS): 1) diagnosis Relapsing Remitting MS since 1 year or longer, 2) Expanded Disability Status Scale (EDSS) score less than or equal to 4.0, 3) no symptoms suggestive of a relapse, 4) no relapse in the previous 4 weeks, 5) willing and capable to participate in the investigations mentioned in the study protocol. For partners of people with MS: willing and capable to participate in the investigations mentioned in the study protocol.
Exclusion criteria
Exclusion criteria: 1) Progressive type of multiple sclerosis (MS), 2) Diagnosis MS since less than 1 year, 3) Expanded Disability Status Scale (EDSS) score less higher than 4.0, 4) Symptoms suggestive of a relapse, 5) Relapse in last 4 weeks, 6) not capable to participate in the investigations mentioned in the study protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-efficacy-control, as measured by the Multiple Sclerosis Self-Efficacy-18 control score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Self-efficacy-function, MSSES-18 (function score); Problem-related autonomy, Impact on Participation and Autonomy (IPA-32) problem-related score; Limitations-related autonomy, IPA-32 limitations-score; health-related quality of life, Multiple Sclerosis Quality of Life-54 (MSQoL-54) questionnaire (mental and physical scores); anxiety and depression, Hospital Anxiety and Depression Scale-14 (HADS-14) (anxiety and depression scores); cost effectiveness and cost utility, EQ-5D-5L, costs questionnaire; neurological symptoms and handicap, Expanded Disability Status Scale (EDSS) (only 1 week before CDT). | — |
Countries
Netherlands